Innovative engineering approaches for organoid research
Official title: Organoids: Engineering Innovative Approaches for Basic and Translational Insight
Funded at Keystone Symposia · NIH-11165647 · Data updated 2026-11-12
This conference is all about bringing together scientists to share new ideas on creating tiny lab-made organs, which can help us learn more about human health and improve treatments for diseases.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Keystone Symposia NIH-funded |
| Lab location | 1 site (Silverthorne, United States) |
| Project start | April 18, 2025 |
| Project end | March 31, 2026 |
| Funding year | 2025 |
| Award (this year) | $10,000 |
| NIH project number | 1R13HD118742-01 |
| Project ID | NIH-11165647 on NIH RePORTER |
Who could benefit from this research
✓Could help
Patients interested in cutting-edge treatments and advancements in regenerative medicine may benefit from this research.
✕Less likely to help
Patients who are not engaged in research or do not have access to advanced medical facilities may not benefit from this research.
What this research studies
This research involves a conference that focuses on the engineering of organoids, which are miniaturized and simplified versions of organs created in the lab. The conference will explore advanced techniques such as 3D bioprinting and programmable biomaterials to improve our understanding of human biology and develop new models for drug testing and regenerative medicine. Attendees will include scientists from various fields who will share insights and collaborate on innovative methods to enhance organoid technology. This event aims to bridge the gap between basic science and clinical applications, fostering advancements in medical practice.
Why it matters
Potential benefit: If successful, this research could lead to improved models for drug testing and new treatments for various diseases.
How similar studies have gone: Previous conferences and research in organoid engineering have shown promising results, indicating a strong potential for success in this area.
Where this research is happening
-
Keystone Symposia
Silverthorne, United States Active
Researchers
- Principal investigator: Sheppard, Terry L. — Keystone Symposia
- Study coordinator: Sheppard, Terry L.
Related research
Other NIH-funded projects on the same topics.
-
Understanding how the immune system protects against malaria
This study is all about a conference where experts will share the latest ideas and discoveries on how our immune system fights malaria, which could lead to better treatments and vaccines for patients and families affected by this disease.
-
Exploring new ways to deliver drugs to the brain.
This study is all about a conference where experts are sharing new ideas on how to get medicines directly to the brain, which is really important for helping people with conditions like Alzheimer's and brain tumors.
-
Understanding how genetic variations affect human development and aging
This study is bringing together experts to talk about how having different genetic cells in the same person can affect our growth and aging, helping us learn more about how these variations might be connected to health and diseases.
-
Understanding the differences in tuberculosis from lab models to human cases
This study is all about a conference where scientists will come together to share ideas on how tuberculosis affects people differently and how treatments can be improved, with the hope of finding better ways to manage this serious disease.
-
Understanding how myeloid cells function in different tissue environments
This study is all about a conference where scientists will talk about how important immune cells called myeloid cells work in different parts of the body, and by sharing their findings, they hope to discover better treatments for diseases related to the immune system that could help patients like you.
-
Exploring new ways to use antibodies as treatments for various diseases
This study is all about a conference where experts will share new ideas on how to make antibody treatments better for diseases like cancer and autoimmune disorders, and they'll also talk about how technology can help improve these therapies, which could lead to better options for patients.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.